Primary Malignant Melanoma of the Cervix: A Case Report and a Review of the Literature
Open Access
- 3 September 2020
- journal article
- review article
- Published by Hindawi Limited in Case Reports in Oncological Medicine
- Vol. 2020, 1-9
- https://doi.org/10.1155/2020/7206786
Abstract
Background. Gynecologic melanomas are extremely rare malignancies, and primary malignant melanoma of the cervix (PMMC) is the rarest among them all, with less than 100 cases reported so far. Although some conditions have been correlated with the pathogenesis of this entity, no specific risk factor has been yet identified, with vaginal bleeding being the most common symptoms. The diagnosis is based on physical examination with speculum assessment and cytologic and histopathologic findings accompanied with immunohistochemical staining of lesions biopsies. Case Presentation. We report a case of PMMC in a 34-year-old para-2 patient, among the youngest cases of PMMC reported, that presented to our clinic for routine examination. Gynecologic examination demonstrated a dark, heavily fully pigmented cervical growth completely covering the entire external cervical os. Biopsy obtained and showed malignant melanoma. She underwent radical hysterectomy with bilateral salpingo-oophorectomy and pelvic lymphadenectomy. The pathological diagnosis was FIGO stage IB1 PMMC. Despite 2 courses of anti-PD-1 antibody (Nivolumab) treatment, the patient passed away 13 months after diagnosis (12 months after surgery). Conclusions. Early diagnosis and subsequently early treatment are of high importance regarding patients prognosis and survival. No standardized protocols or treatment guidelines specific for this rare cancer have been issued; thus, clinicians are called to assess each case individually. Current treatment options are based on surgical excision mostly with radical hysterectomy, but in advanced or recurrent state of the disease, other treatment modalities, such as chemotherapy, radiotherapy, and immunotherapy, can be employed. Prognosis for these patients is very poor, and survival rate remains extremely low, with the median OS reported being less than 2 years. Reporting and publishing of such cases are both of paramount importance for the better understanding of this uncommon cervical malignancy, and further biological and clinical investigations are required for more suitable and effective therapies to be determined. A new staging system, specific to PMMC, could be of great use for the better correlation of the diseases stage and prognosis of these patients.This publication has 59 references indexed in Scilit:
- Cytomorphology of unusual primary tumors in the Pap testCytojournal, 2013
- Primary malignant melanoma of uterine cervix with probable origin from benign cervical melanosisBMJ Case Reports, 2013
- Coexisting Malignant Melanoma and Blue Nevus of the Uterine Cervix: An Unusual CombinationCase Reports in Pathology, 2012
- A literature overview of primary cervical malignant melanoma: An exceedingly rare cancerCritical Reviews in Oncology/Hematology, 2012
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaThe New England Journal of Medicine, 2010
- Metastatic malignant melanoma of the uterine cervix: First diagnosed on liquid‐based cytologyDiagnostic Cytopathology, 2008
- Primary Uterine Cervix Melanoma Resembling Malignant Peripheral Nerve Sheath Tumor: A Case ReportInternational Journal of Gynecological Pathology, 2008
- Primary mucosal melanomaJournal of the American Academy of Dermatology, 2007
- Primary Melanoma of the Uterine Cervix After Supracervical HysterectomyActa Cytologica, 2007
- Malignant melanoma of the female genital tract A report of nine cases in the Chinese of Hong KongPathology, 1991